who.int
55%
713
G7 leaders commit US$ 4.3 billion to finance global equitable access to tests, treatments and vaccines in 2021
The ACT Accelerator partnership welcomes over US$ 4.3 billion of new investments from the USA, Germany, the European Commission, Japan, and Canada to fund the development and equitable rollout of the tests, treatments and vaccines needed to end the acute phase of the COVID-19 pandemic.Today’s commitments bring the amount committed to date to US$ 10.3 billion, leaving a funding gap of US$ 22.9 billion to fully fund the ACT Accelerator’s work in 2021. The UK’s commitment to share vaccine surplus with developing countries is also welcomed and joins similar commitments made by Canada, France, Norway and the European Union. Global Health leaders reiterated, however, that without further significant financial commitments, access to COVID-19 tools